The use of a micro-bubble contrast agent to allow visualization of the biliary tree. Read more about The use of a micro-bubble contrast agent to allow visualization of the biliary tree.
De novo malignancies following liver transplantation: a case-control study with long-term follow-up. Read more about De novo malignancies following liver transplantation: a case-control study with long-term follow-up.
Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years. Read more about Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years.
High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome. Read more about High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome.
Objective measures of health-related quality of life over 24 months post-liver transplantation. Read more about Objective measures of health-related quality of life over 24 months post-liver transplantation.
Exercise capacity and muscle structure in kidney recipient and twin donor. Read more about Exercise capacity and muscle structure in kidney recipient and twin donor.
Frequent salvage of ruptured renal allografts: a large single center experience. Read more about Frequent salvage of ruptured renal allografts: a large single center experience.
Live donor renal transplants using kidneys with arteriographic evidence of mild renovascular disease. Read more about Live donor renal transplants using kidneys with arteriographic evidence of mild renovascular disease.
A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function. Read more about A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function.
Flow cytometry crossmatching as a predictor of acute rejection in sensitized recipients of cadaveric renal transplants. Read more about Flow cytometry crossmatching as a predictor of acute rejection in sensitized recipients of cadaveric renal transplants.
